Robin Kral

Corporate Officer/Principal presso REATA PHARMACEUTICALS, INC.

Consumer Services

Health Technology

Posizioni attive di Robin Kral

Società	Posizione	Inizio	Fine
REATA PHARMACEUTICALS, INC.	Corporate Officer/Principal	01/01/2004	-

Società	Posizione	Inizio	Fine
The University of Texas Southwestern Medical Center	Corporate Officer/Principal	-	-
NPS PHARMACEUTICALS, INC.	Corporate Officer/Principal	-	-

Texas Tech University	Graduate Degree
David Eccles School of Business	Masters Business Admin

Distribuzione geografica

Stati Uniti

Posizioni

Corporate Officer/Principal	3
Graduate Degree	1
Undergraduate Degree	1

Settori

Consumer Services	4
Health Technology	3

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Aziende private	2
Reata Pharmaceuticals, Inc. Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX.	Health Technology
NPS Pharmaceuticals, Inc. NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ.	Health Technology

Aziende private

Health Technology